tradmap

ZBH Earnings Zimmer Biomet

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$2 $4 $9 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $4B $8B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$379M $717M $2B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
$0 $1 $2 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $1B $2B Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
$0 $210M $419M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–60 of 60
Q2 20262026-06-301.032026-08-0510-Q
Q1 20262026-03-311.222026-05-0110-Q
Q4 2025 (derived)2025-12-310.712026-02-2010-K
FY 20252025-12-313.552026-02-2010-K
Q3 20252025-09-301.162025-11-0510-Q
Q2 20252025-06-300.772025-08-0710-Q
Q1 20252025-03-310.912025-05-0510-Q
Q4 2024 (derived)2024-12-311.182025-02-2510-K
FY 20242024-12-314.432025-02-2510-K
Q3 20242024-09-301.232024-10-3010-Q
Q2 20242024-06-301.182024-08-0710-Q
Q1 20242024-03-310.842024-05-0210-Q
Q4 2023 (derived)2023-12-312.002024-02-2310-K
FY 20232023-12-314.882024-02-2310-K
Q3 20232023-09-300.772023-11-0710-Q
Q2 20232023-06-301.002023-08-0110-Q
Q1 20232023-03-311.112023-05-0210-Q
Q4 2022 (derived)2022-12-31-0.622023-02-2410-K
FY 20222022-12-311.102023-02-2410-K
Q3 20222022-09-300.922022-11-0210-Q
Q2 20222022-06-300.732022-08-0210-Q
Q1 20222022-03-310.072022-05-0510-Q
Q4 2021 (derived)2021-12-31-0.392022-02-2510-K
FY 20212021-12-311.912022-02-2510-K
Q3 20212021-09-300.692021-11-0410-Q
Q2 20212021-06-300.672021-08-0310-Q
Q1 20212021-03-310.942021-05-0410-Q
Q4 20202020-12-311.592021-02-2210-K
FY 20202020-12-31-0.672021-02-2210-K
Q3 20202020-09-301.162020-11-0610-Q
Q2 20202020-06-30-1.002020-08-0510-Q
Q1 20202020-03-31-2.462020-05-1110-Q
Q4 20192019-12-311.542020-02-2110-K
FY 20192019-12-315.472020-02-2110-K
Q3 20192019-09-302.082019-11-0510-Q
Q2 20192019-06-300.652019-08-0510-Q
Q1 20192019-03-311.202019-05-0610-Q
Q4 20182018-12-31-4.422019-02-2610-K
FY 20182018-12-31-1.862019-02-2610-K
Q3 20182018-09-300.792018-11-0110-Q
Q2 20182018-06-300.902018-08-0610-Q
Q1 20182018-03-310.852018-05-0810-Q
Q4 20172017-12-316.032018-02-2710-K
FY 20172017-12-318.902018-02-2710-K
Q3 20172017-09-300.482017-11-0610-Q
Q2 20172017-06-300.902017-08-0810-Q
Q1 20172017-03-311.472017-05-0910-Q
Q4 20162016-12-310.342017-03-0110-K
FY 20162016-12-311.512017-03-0110-K
Q3 20162016-09-300.782016-11-0810-Q
Q2 20162016-06-30-0.162016-08-0810-Q
Q1 20162016-03-310.542016-05-1010-Q
Q4 20152015-12-310.622016-02-2910-K
FY 20152015-12-310.772016-02-2910-K
Q3 20152015-09-300.112015-11-0910-Q
Q2 20152015-06-30-1.002015-08-1010-Q
Q1 20152015-03-310.992015-05-0710-Q
Q4 20142014-12-310.892015-02-2310-K
FY 20142014-12-314.202015-02-2310-K
Q3 20142014-09-301.012014-11-0510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.